2026 Crohn’s & Colitis Congress
The Latest
Surgical strategy for perianal Crohn's: Lessons from TOpCLASS
-
by Doug Brunk
MRI-guided staging helps reshape surgical decision-making.
Creeping fat in Crohn's may turn harmful
-
by Doug Brunk
Even though it is common, the condition has not been studied much.
MRI-based standard may predict outcomes in perianal Crohn's
-
by Doug Brunk
The TopCLASS definition identifies healing based on three criteria.
Postoperative Crohn’s: What’s changed?
-
by Doug Brunk
The concept of reusing anti-TNF therapy after surgery is gaining traction.
Expert spotlights advances in ulcerative colitis treatment
-
by Doug Brunk
“Appendicectomy is a viable and safe strategy for reducing the relapse rate in patients with UC compared to standard medical therapy alone,” Dr. Kara De Felice said.
Hospital care for IBD gets practical refresh
-
by Doug Brunk
“IBD experts around the country are receiving many more calls from community gastroenterologists for advice treating their hospitalized patients,” Dr. Shirley Cohen-Mekelburg said.
New Crohn's data spotlight promising therapies
-
by Doug Brunk
Beyond drugs, interest is growing in diet-based treatments.
Four reasons to add intestinal ultrasound to your practice
-
by Doug Brunk
“It's really made its way already into the mainstream of IBD care,” Dr. Rishika Chugh said.
Upadacitinib in pediatric IBD: 52-week results
-
by Doug Brunk
Response in those with ulcerative colitis was especially strong.
FMT improves IBD remission, meta-analysis suggests
-
by Doug Brunk
Researchers evaluated 7 trials involving 542 patients with UC or CD.
GLP-1 therapy in Crohn's disease: Fewer steroids, hospitalizations
-
by Doug Brunk
“What stood out most was the consistent association between GLP-1 receptor agonist use and lower steroid dependence."
